Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

被引:270
作者
Orsulic, S
Li, Y
Soslow, RA
Vitale-Cross, LA
Gutkind, JS
Varmus, HE
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1535-6108(01)00002-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have developed a mouse model for ovarian carcinoma by using an avian retroviral gene delivery technique for the introduction of multiple genes into somatic ovarian cells of adult mice. Ovarian cells from transgenic mice engineered to express the gene encoding the avian receptor TVA were efficiently infected in vitro with multiple vectors carrying coding sequences for oncogenes and marker genes. When target cells were derived from TVA transgenic mice deficient for p53, the addition of any two of the oncogenes c-myc, K-ras, and Akt were sufficient to induce ovarian tumor formation when infected cells were injected at subcutaneous, intraperitoneal, or ovarian sites. We demonstrated that the ovarian surface epithelium is the precursor tissue for these ovarian carcinomas, and that introduction of oncogenes causes phenotypic changes in the ovarian surface epithelial cells. The induced ovarian tumors in mice resembled human ovarian carcinomas in their rapid progression and intraperitoneal metastatic spread.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 49 条
[1]  
ADAMS AT, 1981, CANCER RES, V41, P2063
[2]   Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[3]  
Aunoble B, 2000, INT J ONCOL, V16, P567
[4]   C-MYC AMPLIFICATION IN OVARIAN-CANCER [J].
BAKER, VV ;
BORST, MP ;
DIXON, D ;
HATCH, KD ;
SHINGLETON, HM ;
MILLER, D .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :340-342
[5]   A RECEPTOR FOR SUBGROUP-A ROUS-SARCOMA VIRUS IS RELATED TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR [J].
BATES, P ;
YOUNG, JAT ;
VARMUS, HE .
CELL, 1993, 74 (06) :1043-1051
[6]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[7]  
2-L
[8]   MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[9]   Human ovarian cancer of the surface epithelium [J].
Berchuck, A ;
Carney, M .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (05) :541-544
[10]   MONOCLONAL-ANTIBODIES AGAINST TROPHECTODERM-SPECIFIC MARKERS DURING MOUSE BLASTOCYST FORMATION [J].
BRULET, P ;
BABINET, C ;
KEMLER, R ;
JACOB, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :4113-4117